Physicists have successfully played a mind-bending “quantum game” using a real-world quantum computer, in which lasers ...

In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report), with a price ...

In a dramatic leap for astrophysics, Chinese researchers have recreated a key cosmic process in the lab: the acceleration of ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Bipolar membranes (BPMs) are a unique construction of ion exchange membranes with ...

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with ...

Ionis Pharmaceuticals (IONS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States ...

CARLSBAD, Calif., April 16, 2025--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, April 30th at 11:30 a.m. Eastern Time to discuss its ...

Plasma discharge in the ASDEX Upgrade fusion device. The plasma edge is guided to the tungsten divertor plates at the bottom. (Photographic resolution limited by performance of the CCD camera used.) ...

Get Instant Summarized Text (Gist) New atomic data reveal the impact of charged ions from coronal mass ejections (CMEs) on space weather. Using a high-resolution reaction microscope spectrometer ...

TD Cowen analyst Yaron Werber maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report) today and set a price target of $59.00.